Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Depot medroxyprogesterone acetate users exhibit decreased endometrial tissue inhibitors of metalloproteinases and increased T lymphocytes, suggesting an altered matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in abnormal uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (44)
- Changes in vascular basement membrane in the endometrium of Norplant users via openalex
- Dating the Endometrial Biopsy via openalex
- Progesterone receptor in Norplant endometrium via openalex
- Secretion of matrix metalloproteinases by human endometrial cells in vitro via openalex
- The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation via openalex
- doi:10.1093/humrep/11.suppl_2.124 via openalex
- doi:10.1093/oxfordjournals.humrep.a019300 via openalex
- doi:10.1093/oxfordjournals.humrep.a019474 via openalex
- doi:10.1093/humrep/13.5.1210 via openalex
- doi:10.1093/molehr/3.9.735 via openalex
- doi:10.1016/s0165-0378(00)00082-6 via openalex
- doi:10.1016/s0960-0760(97)00119-2 via openalex
- doi:10.1073/pnas.93.17.9120 via openalex
- doi:10.1093/humrep/11.suppl_2.165 via openalex
- doi:10.1530/jrf.0.1070043 via openalex
- doi:10.1177/10454411930040020401 via openalex
- doi:10.1095/biolreprod59.3.693 via openalex
- doi:10.1053/beog.1999.0018 via openalex
- doi:10.1093/humrep/14.3.793 via openalex
- doi:10.1093/humupd/6.1.16 via openalex
- doi:10.1111/j.1600-0897.1995.tb00956.x via openalex
- doi:10.1016/0010-7824(91)90075-q via openalex
- doi:10.1093/humrep/11.suppl_2.31 via openalex
- doi:10.1080/00140137208928231 via openalex
- doi:10.1210/jcem.85.12.7020 via openalex
- doi:10.1093/humrep/15.suppl_3.162 via openalex
- doi:10.1093/humrep/15.suppl_3.135 via openalex
- doi:10.1677/joe.0.141r001 via openalex
- doi:10.1093/oxfordjournals.humrep.a137904 via openalex
- doi:10.1093/humrep/15.suppl_3.120 via openalex
- doi:10.1016/s0165-0378(02)00011-6 via openalex
- doi:10.1093/molehr/7.6.559 via openalex
- doi:10.1172/jci117461 via openalex
- doi:10.1016/s1071-5576(97)86381-2 via openalex
- doi:10.1093/humrep/15.1.123 via openalex
- doi:10.1016/0303-7207(94)03442-v via openalex
- doi:10.1093/oxfordjournals.humrep.a135750 via openalex
- doi:10.1074/jbc.270.28.16518 via openalex
- doi:10.1093/humrep/11.suppl_2.35 via openalex
- doi:10.1016/s0002-9378(16)32491-7 via openalex
- doi:10.1093/humrep/11.suppl_2.45 via openalex
- doi:10.1093/oxfordjournals.humrep.a019416 via openalex
- doi:10.1093/humrep/13.5.1218 via openalex
- doi:10.2307/1271101 via openalex
Cited by (9)
- The uterine natural killer cell, cytotoxic T lymphocyte, and granulysin levels are elevated in the endometrium of women with nonstructural abnormal uterine bleeding 2022
- Matrix metalloproteinases-2, -7 and tissue metalloproteinase inhibitor-1 expression in human endometrium 2018
- Abnormal bleeding in postmenopausal hormone users-What do we know today? 2009
- Best Practice & Research Clinical Obstetrics and Gynaecology 2009
- Bleeding with menopausal hormone therapy 2008
- Endometrial bleeding during hormone therapy: the effect of progestogens 2007
- Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users 2006
- Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors 2006
- Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding 2003
Source provenance
- openalex
- last seen: 2026-05-11T05:53:22.067783+00:00
- pubmed
- last seen: 2026-10-08T21:00:31.392641+00:00